Inventor
Melwyn Abreo
Inventor
Jamul, CA, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
A61FFilters implantable into blood vessels5%
C07KPeptides5%
A61JContainers specially adapted for medical or pharmaceutical purposes4%
C07CAcyclic or carbocyclic compounds1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,751,331Treatment of sunburn using analgesics and antihistamines202010,682,324Healing topical composition20209,895,360'Treatment of sunburn using analgesics and antihistamines'20188,957,095'Treatment of sunburn using analgesics and antihistamines'20158,383,628'Pyridyl derivatives and their use as therapeutic agents'20138,153,636'Pyridyl derivatives and their use as therapeutic agents'20128,030,488'Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents'20117,943,760'Non-nucleotide composition for inhibiting platelet aggregation'20117,919,484'Combination therapy'20117,763,618'Pyridyl derivatives and their use as therapeutic agents'20107,754,711'Pyridazine derivatives and their use as therapeutic agents'20107,749,980'Non-nucleotide compositions and method for treating pain'20107,605,161'Pyridyl derivatives and their use as therapeutic agents'20097,592,445'Non-nucleotide composition and method for inhibiting platelet aggregation'20097,456,180'Piperazine derivatives and their use as therapeutic agents'20087,368,438'Non-nucleotide compositions and method for inhibiting platelet aggregation'20087,335,658'Pyridazine derivatives and their use as therapeutic agents'20087,335,648'Non-nucleotide composition and method for inhibiting platelet aggregation'20087,115,658'Inhibitors of hepatitis C virus RNA-dependent RNA polymerase'20066,964,957'Fused pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity'20056,495,699'Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use'20026,306,892'Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use'20016,174,915'Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses'20016,008,243'Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use'19995,985,900'Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses'19995,948,793'3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release'19995,914,328'Heterocyclic ether compounds useful in controlling neurotransmitter release'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2006Patents assigned to AGOURON PHARMA (7)· patent assignee history
1999–2002Based in Imperial Beach, CA, US· patent location history
2005–2020Based in Jamul, CA, US· patent location history
2008–2013Patents assigned to XENON PHARMACEUTICALS INC (9)· patent assignee history
2008–2011Patents assigned to INSPIRE PHARMACEUTICALS INC (5)· patent assignee history
2012–2015Patents assigned to ABREO MELWYN (3)· patent assignee history
2015–2020Patents assigned to SEPHORIS PHARMACEUTICALS LLC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| XENON PHARMACEUTICALS INC | 9 | 2008–2013 |
| AGOURON PHARMA | 7 | 1999–2006 |
| INSPIRE PHARMACEUTICALS INC | 5 | 2008–2011 |
| ABREO MELWYNself | 3 | 2012–2015 |
| SEPHORIS PHARMACEUTICALS LLC | 3 | 2015–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Jamul, California, US | 20 | 2005–2020 |
| Imperial Beach, California, US | 7 | 1999–2002 |